The Case Against Pay Transparency
Harvard Business
SEPTEMBER 30, 2016
As a result, some of these Harvard employees earned in excess of $30 million in yearly pay, due to performance that was truly exceptional against industry benchmarks. For years, large pharmaceutical firms purchased small biotech firms with promises to keep their “entrepreneurial rewards” intact.
Let's personalize your content